Open AccessImplications of antibacterial scheduling in newborns in clinical nursing practice
Author(s) -
Waltemberg Moreira da Silva,
Regina Cláudia Melo Dodt,
Rhanna Emanuela Fontenele Lima de Carvalho,
Amaurílio Oliveira Nogueira,
Luis Gustavo Oliveira Farias,
Edna Maria Camelo Chaves
Publication year - 2015
Publication title -
rev rene
Language(s) - English
Resource type - Journals
eISSN - 2175-6783
pISSN - 1517-3852
DOI - 10.15253/2175-6783.2015000600006
Subject(s) - amikacin , medical record , medicine , furosemide , drug , vancomycin , cefepime , health care , antibiotics , pharmacology , chemistry , biochemistry , antibiotic resistance , imipenem , biology , economic growth , bacteria , economics , genetics , staphylococcus aureus
Objective: to identify drug associations related to the scheduling of antibiotics in the neonatal unit which may cause drug interactions. Methods: a retrospective documentary study using medical records of newborns admitted into the neonatal unit. The sample was composed of 92 newborn medical records. Data were collected through forms and presented in tables and figures. Results: associations in drug scheduling leading to pharmacokinetic interactions were found in 24 medical records, highlighting associations between amikacin and ampicillin, cefepime and furosemide, and vancomycin and furosemide. Conclusion: the scheduling of drugs at the same time represents a risk to newborn's health due to the possibility of drug interactions.